- Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe2021 | Second Faculty of Medicine
- Nationwide observational study of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the Czech Republic2022 | Second Faculty of Medicine, Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab2021 | First Faculty of Medicine
- Protection by Vaccines and Previous Infection Against the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 22022 | First Faculty of Medicine, Faculty of Physical Education and Sport, Third Faculty of Medicine
- Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?2024 | First Faculty of Medicine
- Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 20202023 | Central Library of Charles University
- Protection by Vaccines and Previous Infection Against the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 22022 | Faculty of Physical Education and Sport, Third Faculty of Medicine
- Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD)2020 | Second Faculty of Medicine
- Predictors of Severity of Influenza-Related Hospitalizations: Results From the Global Influenza Hospital Surveillance Network (GIHSN)2023 | Third Faculty of Medicine
- The Incidence and Associated Factors of Early Neurological Deterioration After Thrombolysis Results From SITS Registry2020 | Faculty of Medicine in Pilsen
